TI CEO Rich Templeton to speak at Credit Suisse investor conference

December 2, 2020, 10:50 a.m. Eastern time

PR Newswire

DALLAS, Nov. 12, 2020 /PRNewswire/ — Texas Instruments Incorporated (TI) (Nasdaq: TXN) Chairman, President and Chief Executive Officer Rich Templeton will speak at the virtual Credit Suisse 24th Annual Technology Conference on Tuesday, December 2, at 10:50 a.m. Eastern time. Templeton will field questions from analysts and investors, as well as discuss TI’s business outlook and its strategy to address key markets for its analog and embedded processing technologies and how these capabilities position the company for growth.

The audio webcast for the conference can be accessed live through the Investor Relations section (www.ti.com/ir) of TI’s website. An archived replay will be available on the website after his remarks.  

About Texas Instruments

Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures, tests and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, communications equipment and enterprise systems. Our passion to create a better world by making electronics more affordable through semiconductors is alive today, as each generation of innovation builds upon the last to make our technology smaller, more efficient, more reliable and more affordable – making it possible for semiconductors to go into electronics everywhere. We think of this as Engineering Progress. It’s what we do and have been doing for decades. Learn more at TI.com.

TXN-G

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ti-ceo-rich-templeton-to-speak-at-credit-suisse-investor-conference-301172245.html

SOURCE Texas Instruments Incorporated

Liberty All-Star® Growth Fund, Inc. October 2020 Monthly Update

PR Newswire

BOSTON, Nov. 12, 2020 /PRNewswire/ — Below is the October 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG)                       

Liberty All-Star Growth Fund, Inc.         
Ticker: ASG
Monthly Update, October, 2020       

Investment Approach:
Fund Style: All-Cap Growth             

Fund Strategy: Combines three growth style investment managers, each with a distinct capitalization focus (small-, mid- and large-cap) selected and continuously monitored by the Fund’s Investment Advisor.


Investment Managers:                     

          Weatherbie Capital, LLC
          Small-Cap Growth 
          Congress Asset Management Company, LLP
          Mid-Cap Growth 
          Sustainable Growth Advisers, LP 
          Large-Cap Growth

                               


Top 20 Holdings at Month-End         

  (31.3% of equity portfolio)       

1

FirstService Corp.                                     

2.1%

2

Paylocity Holding Corp.                               

2.1%

3

Nevro Corp.                                                  

2.1%

4

Chegg, Inc.                                                

2.0%

5

Microsoft Corp.                                             

1.7%

6

Visa, Inc.                                                     

1.6%

7

Alphabet, Inc.                                                 

1.6%

8

Facebook, Inc.                                              

1.6%

9

Amazon.com, Inc.                                     

1.6%

10

Insulet Corp.                                                 

1.5%

11

Generac Holdings, Inc                                  

1.4%

12

Progyny, Inc.                                                 

1.4%

13

Casella Waste Systems, Inc.                        

1.4%

14

ACADIA Pharmaceuticals, Inc.                   

1.4%

15

Workday, Inc.                                                

1.4%

16

Ollie’s Bargain Outlet Holdings, Inc.           

1.3%

17

Abbott Laboratories                                     

1.3%

18

Monolithic Power Systems, Inc.                   

1.3%

19

FleetCor Technologies, Inc.                        

1.3%

20

UnitedHealth Group, Inc.                              

1.2%

Holdings are subject to change.

 


Monthly Performance         

Performance                                       

    NAV               

   Market Price              

     Premium

Beginning of month value                  

$6.96

$7.11

2.2%

End of month value                          

$6.95

$7.20

3.6%

Performance for month                      

-0.14%

-1.27%

Performance year-to-date                  

19.92%

18.31%

 


Net Assets at Month-End ($millions)

Total                            

$291.0

Equities                       

$285.1

Percent Invested           

98.0%

 


Sector Breakdown (% of equity portfolio)*            

Information Technology                    

30.3%

Health Care                                        

26.1%

Consumer Discretionary                  

12.5%

Industrials                                           

12.4%

Financials                                           

4.8%

Communication Services                   

4.6%

Real Estate                                        

3.9%

Materials                                            

3.0%

Consumer Staples                              

2.1%

Energy                                               

0.3%

Total Market Value                              

100.0%

*Based on Standard & Poor’s and MSCI Barra Global Industry Classification Standard (GICS).

 


New Holdings

Eargo, Inc.     

Entegris, Inc.

 


Holdings Liquidated

Varian Medical Systems, Inc.

 

The net asset value (NAV) of a closed-end fund is the market value of the underlying investments (i.e., stocks and bonds) in the Fund’s portfolio, minus liabilities, divided by the total number of Fund shares outstanding. However, the Fund also has a market price; the value at which it trades on an exchange. If the market price is above the NAV the Fund is trading at a premium. If the market price is below the NAV the Fund is trading at a discount.

Performance returns for the Fund are total returns, which includes dividends, and are net of management fees and other Fund expenses. Returns are calculated assuming that a shareholder reinvested all distributions and all primary rights in the Fund’s rights offering were exercised. Past performance cannot predict future investment results.

Performance will fluctuate with changes in market conditions. Current performance may be lower or higher than the performance data shown. Performance information shown does not reflect the deduction of taxes that shareholders would pay on Fund distributions or the sale of Fund shares. Shareholders must be willing to tolerate significant fluctuations in the value of their investment. An investment in the Fund involves risk, including loss of principal.

Sources of distributions to shareholders may include ordinary dividends, long-term capital gains and return of capital.   The final determination of the source of all distributions in 2020 for tax reporting purposes will be made after year end.  The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during its fiscal year and may be subject to changes based on tax regulations. Based on current estimates no portion of the distributions consists of a return of capital. These estimates may not match the final tax characterization (for the full year’s distributions) contained in shareholder 1099-DIV forms after the end of the year.                    

All data is as of October 31, 2020 unless otherwise noted. 

Liberty All-Star® Growth Fund, Inc.
1-800-241-1850
www.all-starfunds.com
[email protected]                           

                                   

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/liberty-all-star-growth-fund-inc-october-2020-monthly-update-301172260.html

SOURCE Liberty All-Star Growth Fund, Inc.

Liberty All-Star Equity Fund October 2020 Monthly Update

PR Newswire

BOSTON, Nov. 12, 2020 /PRNewswire/ — Below is the October 2020 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA)

Liberty All-Star Equity Fund
Ticker: USA
Monthly Update, October, 2020

Investment Approach:
Fund Style: Large-Cap Core
Fund Strategy: Combines three value-style and two growth-style investment managers. Those selected demonstrate a consistent investment philosophy, decision making process, continuity of key people and above-average long-term results compared to managers with similar styles.


Investment Managers:

Value Managers:

Aristotle Capital Management, LLC 

Fiduciary Management, Inc.              

Pzena Investment Management, LLC                       

Growth Managers:

Sustainable Growth Advisers, LP     

TCW Investment Management Company

 


Top 20 Holdings at Month-End

(32.8% of equity portfolio)

1

Amazon.com, Inc.

2.6%

2

PayPal Holdings, Inc.

2.2%

3

Adobe, Inc.

2.2%

4

Alphabet, Inc.

2.2%

5

Facebook, Inc.

2.1%

6

Visa, Inc.

2.0%

7

Danaher Corp.

1.9%

8

Microsoft Corp.

1.9%

9

salesforce.com, Inc.

1.8%

10

UnitedHealth Group, Inc.

1.6%

11

Sony Corp.

1.5%

12

JPMorgan Chase & Co.

1.4%

13

ServiceNow, Inc.

1.4%

14

Berkshire Hathaway, Inc.

1.3%

15

Chubb, Ltd.

1.3%

16

IHS Markit, Ltd.

1.2%

17

Equinix, Inc.

1.2%

18

Capital One Financial Corp.

1.0%

19

Masco Corp.

1.0%

20

Dollar General Corp.

1.0%

Holdings are subject to change.

 


Monthly Performance:

Performance

NAV

Market Price

Discount

Beginning of month value

$6.46

$6.01

-7.0%

End of month value

$6.43

$5.80

-9.8%

Performance for month

-0.46%

-3.49%

Performance year-to-date

0.58%

-7.54%

           


Net Assets at Month-End ($millions)

Total

$1,382.7

Equities

$1,345.4

Percent Invested

97.3%

 


Sector Breakdown (% of equity portfolio)*

Information Technology

22.1%

Financials

15.7%

Health Care

14.8%

Consumer Discretionary

14.2%

Industrials

12.1%

Communication Services

6.3%

Materials

4.6%

Consumer Staples

3.7%

Energy

3.1%

Real Estate

2.6%

Utilities

0.8%

Total Market Value

100.0%

*Based on Standard & Poor’s and MSCI Barra Global Industry Classification Standard (GICS).

New Holdings
Edison International
Micron Technology, Inc.

Holdings Liquidated

Stanley Black & Decker, Inc.

The net asset value (NAV) of a closed-end fund is the market value of the underlying investments (i.e., stocks and bonds) in the Fund’s portfolio, minus liabilities, divided by the total number of Fund shares outstanding. However, the Fund also has a  market price; the value at which it trades on an exchange. If the market price is above  the NAV the Fund is trading at a premium. If the market price is below the NAV the Fund is trading at a discount.

Performance returns for the Fund are total returns, which includes dividends, and are net of management fees and other Fund expenses. Returns are calculated assuming that a shareholder reinvested all distributions. Past performance cannot predict future investment results.

Performance will fluctuate with changes in market conditions. Current performance may be lower or higher than the performance data shown. Performance information shown does not reflect the deduction of taxes that shareholders would pay on Fund distributions or the sale of Fund shares. Shareholders must be willing to tolerate significant fluctuations in the value of their investment. An investment in the Fund involves risk, including loss of principal.

Sources of distributions to shareholders may include ordinary dividends, long-term capital gains and return of capital.  The final determination of the source of all distributions in 2020 for tax reporting purposes will be made after year end.  The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during its fiscal year and may be subject to changes based on tax regulations. Based on current estimates a portion of the distributions consists of a return of capital. These estimates may not match the final tax characterization (for the full year’s distributions) contained in shareholder 1099-DIV forms after the end of the year.                    

All data is as of October 31, 2020 unless otherwise noted.              

Liberty All-Star® Equity Fund
1-800-241-1850
www.all-starfunds.com
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/liberty-all-star-equity-fund-october-2020-monthly-update-301172256.html

SOURCE Liberty All-Star Funds

AM Best Affirms Credit Ratings of Castle Harbour Insurance Limited and Harrington Sound Insurance Limited

AM Best Affirms Credit Ratings of Castle Harbour Insurance Limited and Harrington Sound Insurance Limited

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” of Castle Harbour Insurance Limited (Castle Harbour) and Harrington Sound Insurance Limited (Harrington). These companies are captive insurance companies for Schlumberger Limited (Schlumberger) [NYSE:SLB]. The outlook of these Credit Ratings (ratings) is stable. Both captives are domiciled in Bermuda.

The ratings of Castle Harbour and Harrington reflect their balance sheet strength, which AM Best categorizes as strongest, as well as their strong operating performance, neutral business profile and appropriate enterprise risk management (ERM).

The companies are captive insurance companies for Schlumberger, a leading provider of technology, integrated project management and information solutions to customers working in the oil and gas industry worldwide. The ratings reflect that Castle Harbour and Harrington maintain the strongest level of risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR). In addition to excellent operating performance over several years, the ratings take into consideration the important role the captives play in providing their parent customized insurance coverages. The captives carry relatively large limits in the general liability and property lines of business; however, each writes a broad scope of business and has significant geographic diversification. ERM practices are appropriate given the conservative risk culture across the Schlumberger enterprise, defined controls and optimization of the captives’ capital and surplus. Further, AM Best recognizes the financial flexibility afforded the captives by their parent company as well as their strategic importance across Schlumberger.

AM Best remains the leading rating agency of alternative risk transfer entities, with more than 200 such vehicles rated in the United States and throughout the world. For current Best’s Credit Ratings and independent data on the captive and alternative risk transfer insurance market, please visit www.ambest.com/captive.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and AM Best press releases, please view Guide for Media – Proper Use of Best’s Credit Ratings and AM Best Rating Action Press Releases.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Adrienne Stark

Senior Financial Analyst

+1 908 439 2200, ext. 5526

[email protected]

Christopher Sharkey

Manager, Public Relations

+1 908 439 2200, ext. 5159

[email protected]

Dan Teclaw

Senior Financial Analyst

+1 908 439 2200, ext. 5394

[email protected]

Jim Peavy

Director, Communications

+1 908 439 2200, ext. 5644

[email protected]

KEYWORDS: Europe United States North America New Jersey

INDUSTRY KEYWORDS: Insurance Professional Services

MEDIA:

Logo
Logo

INTERCEPT PHARMACEUTICALS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit has Been Filed on Behalf of Shareholders of Intercept Pharmaceuticals, Inc.

Impending Lead Plaintiff Deadline is January 4, 2021

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Intercept Pharmaceuticals, Inc. (“Intercept” or the “Company”) (NASDAQ: ICPT) securities between September 28, 2019 and October 7, 2020 inclusive (the “Class Period”).

All
i
nvestors
who
purchased
shares
of
Intercept Pharmaceuticals, Inc.
a
nd
incurred losses
a
re
u
rged
to contact the firm
i
mmediately at

[email protected]

or (800) 575-0735 or (212) 545-4774.
You may obtain additional information conc
erning the action or

join the case

on our
website
,

www.whafh.com.

If you have incurred losses in the shares of Intercept Pharmaceuticals, Inc.,you may,nolater than January 4, 2021,   request that the Court appoint you lead plaintiff of the proposed class.  


CLICK HERE TO JOIN THIS CASE

The filed complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that:

  • Defendants downplayed the true scope and severity of safety concerns associated with Ocaliva’s use in treating PBC;
  • the foregoing increased the likelihood of an FDA investigation into Ocaliva’s development, thereby jeopardizing Ocaliva’s continued marketability and the sustainability of its sales;
  • any purported benefits associated with OCA’s efficacy in treating NASH were outweighed by the risks of its use;
  • as a result, the FDA was unlikely to approve the Company’s NDA for OCA in treating patients with liver fibrosis due to NASH; and
  • as a result of all the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

On May 22, 2020, Intercept stated that the U.S. Food and Drug Administration (“FDA”) “has notified Intercept that its tentatively scheduled June 9, 2020 advisory committee meeting (AdCom) relating to the company’s [NDA] for [OCA] for the treatment of liver fibrosis due to [NASH] has been postponed” to “accommodate the review of additional data requested by the FDA that the company intends to submit within the next week.”

On this news, Intercept’s stock price fell $11.18 per share, or 12%, to close at $80.51 per share on May 22, 2020.

On June 29, 2020, Intercept disclosed receipt of a Complete Response Letter (“CRL”) from the FDA rejecting its NDA for Ocaliva for the treatment of liver fibrosis due to NASH. According to the CRL, “[t]he FDA recommends that Intercept submit additional post-interim analysis efficacy and safety data from the ongoing REGENERATE study in support of potential accelerated approval and that the long-term outcomes phase of the study should continue.”

On this news, the Company’s stock price fell $30.79 per share, or nearly 40%, to close at $46.70 per share on June 29, 2020.

On October 8, 2020, news outlets reported that the Company was “facing an investigation from the [FDA] over the potential risk of liver injury in patients taking Ocaliva, [Intercept’s] treatment for primary biliary cholangitis, a rare, chronic liver disease.”

On this news, the Company’s stock price fell an additional $3.30 per share, or 8%, to close at $37.69 per share on October 8, 2020.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected][email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

BioSig to Host Business Update Conference Call on November 18, 2020

Westport, CT, Nov. 12, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would host a call on November 18, 2020, at 4:15 PM ET. Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc. will review highlights from the Company’s third quarter of 2020 and discuss corporate initiatives, including ongoing PURE EP™ System installations and commercialization outlook.

Conference Call Details

Date: Wednesday, November 18, 2020
Time: 4:15 PM Eastern Time (ET)
Dial in Number: +1 877-407-8293 / 201-689-8349

A replay will be available for two weeks starting on November 18, 2020, at approximately 7:15 PM ET. To access the replay, please dial +1 877-660-6853 / 201-612-7415. The conference ID# is 13713315.

BioSig’s PURE EP™ System is currently installed in six medical centers across the country. More than 350 patient cases have been completed with the PURE EP™ System to date. BioSig is presently enrolling patients in the clinical trial titled “Novel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study)” at Texas Cardiac Arrhythmia Research Foundation (TCARF) in Austin, Texas and Mayo Clinic Florida Campus in Jacksonville, Florida.

About BioSig Technologies

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

The Company’s first product, PURE EP ™ System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Forward-looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. 

Andrew Ballou
BioSig Technologies, Inc. 
Vice President, Investor Relations 
54 Wilton Road, 2nd floor
Westport, CT 06880
[email protected]
203-409-5444, x133

1347 Property Insurance Holdings, Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A

1347 Property Insurance Holdings, Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A

ST. PETERSBURG, Fla.–(BUSINESS WIRE)–1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”) announced today that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the “Preferred Stock”), for the period commencing on September 15, 2020 and ending on December 14, 2020.

In accordance with the terms of the Company’s 8.00% Cumulative Preferred Stock, Series A, on November 12, 2020, the Board of Directors declared a Preferred Stock cash dividend of $0.50 per share for the period that began on September 15, 2020 and ends on December 14, 2020. The dividend is payable on December 15, 2020 to holders of record on December 1, 2020. The Preferred Stock is currently listed on the Nasdaq Stock Market and trades under the ticker symbol “PIHPP”.

About 1347 Property Insurance Holdings, Inc.

1347 Property Insurance Holdings, Inc. is implementing business plans to operate as a diversified insurance, reinsurance and investment management holding company and is incorporated in Delaware. The Company endeavors to make opportunistic and value-oriented investments in insurance, reinsurance and related businesses. The Company’s principal business operations are conducted through its subsidiaries and affiliates. The Company also provides investment management services to unaffiliated companies.

Additional Information

Additional information about 1347 Property Insurance Holding, Inc., including its Annual Report on Form 10-K for the fiscal year ended December 31, 2019, can be found at the U.S. Securities and Exchange Commission’s website at www.sec.gov, or at PIH’s corporate website: www.1347pih.com.

INVESTOR RELATIONS:

The Equity Group Inc.

Jeremy Hellman, CFA

Vice President

(212) 836-9626 / [email protected]

KEYWORDS: United States North America Florida Delaware

INDUSTRY KEYWORDS: Professional Services Residential Building & Real Estate Insurance Commercial Building & Real Estate Finance Construction & Property

MEDIA:

Logo
Logo

Manchester United PLC Reports First Quarter Fiscal 2021 Results

Manchester United PLC Reports First Quarter Fiscal 2021 Results

Key Points

  • Elite sport will continue matches during the current lockdown in England; European matches and other competitions are also currently expected to continue as planned
  • Broadcasting revenues benefited from five additional matches played in the quarter
  • Club recently launched an official TikTok channel and a Douyin channel in China
  • Strong continued digital engagement year over year has contributed to record breaking Club e-commerce sales of new kits for 2020/21
  • Renewed partnerships with Hong Kong Jockey Club, Chivas and Melitta during the quarter
  • Strong net cash from operating activities due to receipt of deferred sponsorship revenues and a 46.4% year over year reduction in other operating expenses
  • Committed to the FA Football Leadership Diversity Code, strengthening Club efforts to further promote equality, diversity and inclusion

MANCHESTER, England–(BUSINESS WIRE)–
Manchester United (NYSE: MANU; the “Company” and the “Group”) – one of the most popular and successful sports teams in the world – today announced financial results for the 2021 fiscal first quarter ended 30 September 2020.

Management Commentary

Ed Woodward, Executive Vice Chairman, commented, “While the COVID-19 pandemic continues to cause significant disruption, we are optimistic that the recovery and normalisation phase is gradually coming into view. The club’s resilience and our strong commercial business continue to provide a solid foundation and gives us confidence in our long-term outlook beyond the pandemic, both on and off the pitch.”

“We recognise that not all football clubs are in as robust of a financial position and that the Premier League has a responsibility to support the wider English football pyramid. We will continue to push for this support, both through emergency assistance during the pandemic, and through longer-term reforms to ensure that the success of the Premier League is reinforced for the benefit of the national game as a whole.”

“On the pitch, while there is still hard work ahead to achieve greater consistency, we remain absolutely committed to the positive path we are on under Ole as the team continues to develop. We miss playing in front of our fans and we are working hard together with our governing bodies and relevant authorities to ensure that fans can safely return as soon as possible.”

“Finally, I would like to stress our steadfast commitment to increasing equality, diversity and inclusion across our club and the game as a whole. To that end, we were pleased to be among the first clubs to sign up to the FA Football Leadership Diversity Code. Football has made good progress in this area but there is much more work to do and Manchester United is determined to be at the forefront of those efforts.”

Key Financials (unaudited)

£ million (except (loss)/earnings per share)

Three months ended

30 September

 

 

2020

2019

Change

Commercial revenue

59.7

80.4

(25.7%)

Broadcasting revenue

47.6

32.9

44.7%

Matchday revenue

1.7

22.1

(92.3%)

Total revenue

109.0

135.4

(19.5%)

Adjusted EBITDA(1)

20.8

34.8

(40.2%)

Operating (loss)/profit

(27.1)

11.0

 

(Loss)/profit for the period (i.e. net (loss)/income)

(30.3)

1.1

Basic (loss)/earnings per share (pence)

(18.58)

0.69

Adjusted (loss)/profit for the period (i.e. adjusted net (loss)/income)(1)

(24.6)

3.9

Adjusted basic (loss)/earnings per share (pence)(1)

(15.12)

2.35

 

Non-current and current borrowings

499.5

524.8

(4.8%)

Cash and cash equivalents

58.9

140.3

(58.0%)

Net debt(1)/(2)

440.6

384.5

14.6%

(1) Adjusted EBITDA, adjusted (loss)/profit for the period, adjusted basic (loss)/earnings per share and net debt are non-IFRS measures. See “Non-IFRS Measures: Definitions and Use” on page 7 and the accompanying Supplemental Notes for the definitions and reconciliations for these non-IFRS measures and the reasons we believe these measures provide useful information to investors regarding the Group’s financial condition and results of operations.

(2) The gross USD debt principal remains unchanged. The increase in net debt is due to a £81.4 million reduction in cash and cash equivalents at 30 September 2020 compared to 30 September 2019, which reflects the loss of 2020/21 season Matchday advance cash receipts, with new seasonal facility sales currently on hold due to the uncertainties around fans returning to the stadium and the impact of deferred sponsorship payments.

COVID-19 Impact

Operationally, the impact of the pandemic and measures to prevent further spread continues to disrupt our businesses. The Old Trafford Stadium, Museum and Stadium Tour operations remain closed to visitors.

The postponement of the 2019/20 domestic competitions resulted in three Premier League home matches, three Premier League away matches and an FA Cup semi-final away match being played during the first quarter of the fiscal year 2021. All remaining 2019/20 UEFA Europa League matches, which included one home match and a single-leg quarter-final and semi-final, were also played during the quarter. All matches were played behind closed doors.

As a direct result, the 2020/21 Premier League season start was delayed until mid-September 2020 with one Premier League home match, one Premier League away match and two Carabao Cup away matches being played in the quarter. No 2020/21 UEFA Champions League matches were played in the quarter. All matches continue to be played behind closed doors. Furthermore, the first team’s pre-season tour was cancelled this summer due to travel restrictions.

The impact of playing matches behind closed doors and the cancellation of the pre-season tour has had a significant impact on our first quarter Matchday and Commercial fiscal 2021 revenues. This has been partially offset by increased Broadcasting revenues compared to the prior quarter, due to playing the latter stages of the 2019/20 domestic and European competitions in the quarter. The significant revenue impact of COVID-19 has been partially offset by reduced operating costs, principally in respect of matches played behind closed doors, cancellation of the 2020/21 pre-season tour, reduced travel and reduced costs related to the fall in activity at the Old Trafford Megastore.

Looking forward, the COVID-19 pandemic will continue to impact results. Subsequent to the end of the quarter, additional lockdown measures were mandated in the UK which has resulted in the closure of the Megastore, effective 5 November. Given ongoing uncertainty due to the COVID-19 pandemic, including when fans might be allowed to return to the stadium, the Company is not providing revenue or adjusted EBITDA guidance for fiscal 2021 at this time.

Phasing of Premier League games

Quarter 1

Quarter 2

Quarter 3

Quarter 4

Total

2020/21 season*

2

13

14

9

38

2019/20 remaining season

6

6

Total FY 2021

8

13

14

9

44

2019/20 season

7

13

9

3

32

2018/19 season

7

13

11

7

38

*Subject to changes in broadcasting scheduling

Working Capital and Liquidity

As of 30 September 2020, the Company had £58.9 million of cash balances together with access to an additional £150.0 million available under the Company’s revolving credit facilities. Subsequent to the end of the quarter, the company arranged an additional £50.0 million in revolving credit taking total accessible liquidity to £200.0 million. This provides financial flexibility to support the Club through the disruption caused by COVID-19.

Revenue Analysis

Commercial

Commercial revenue for the quarter was £59.7 million, a decrease of £20.7 million, or 25.7%, over the prior year quarter.

  • Sponsorship revenue was £36.5 million, a decrease of £17.1 million, or 31.9%, over the prior year quarter, primarily due to no 2020/21 pre-season tour taking place as a result of COVID-19.
  • Retail, Merchandising, Apparel & Product Licensing revenue was £23.2 million, a decrease of £3.6 million, or 13.4%, over the prior year quarter due to significantly reduced Megastore footfall given matches continue to be played behind closed doors.

Broadcasting

Broadcasting revenue for the quarter was £47.6 million, an increase of £14.7 million, or 44.7%, over the prior year quarter, primarily due playing five more home and away games across all competitions, due to completion of the 2019/20 domestic and UEFA competitions during the current quarter.

Matchday

Matchday revenue for the quarter was £1.7 million, a decrease of £20.4 million, or 92.3%, over the prior year quarter, due to all matches being played behind closed doors. Six home games with fans in attendance were played in the prior year quarter.

Other Financial Information

Operating expenses

Total operating expenses for the quarter were £123.5 million, a decrease of £12.9 million, or 9.5%, over the prior year quarter.

Employee benefit expenses

Employee benefit expenses for the quarter were £71.9 million, an increase of £1.7 million, or 2.4%, over the prior year quarter. This is due to contracted increases in player salaries as a result of participation in the UEFA Champions League, partially offset by reduced salaries arising from player disposals.

Other operating expenses

Other operating expenses for the quarter were £16.3 million, a decrease of £14.1 million, or 46.4%, over the prior year quarter, primarily due to reduced business activity as a result of COVID-19. This includes the impact of no 2020/21 pre-season tour, all matches being played behind closed doors, travel savings and reduced costs related to the fall in activity at the Old Trafford Megastore.

Depreciation and amortization

Depreciation for the quarter was £3.8 million, an increase of £0.2 million, or 5.6%, over the prior year quarter. Amortization for the quarter was £31.5 million, a decrease of £0.7 million, or 2.2%, over the prior year quarter. The unamortized balance of registrations at 30 September 2020 was £353.0 million.

(Loss)/profit on disposal of intangible assets

Loss on disposal of intangible assets for the quarter was £12.6 million, compared to a profit of £12.0 million for the prior year quarter.

Net finance income/(costs)

Net finance income for the quarter was £nil, compared to net finance costs of £8.5 million in the prior year quarter due to a favourable swing in unrealized foreign exchange movements. Underlying net finance costs are consistent with the prior year quarter.

Income tax

The income tax expense for the quarter was £3.2 million, compared to £1.4 million in the prior year quarter.

Cash flows

Overall cash and cash equivalents (including the effects of exchange rate movements) increased by £7.4 million in the quarter to 30 September 2020 compared to the cash position at 30 June 2020.

Net cash inflow from operating activities for the quarter was £62.3 million, compared to net cash outflow from operating activities in the prior year quarter of £14.4 million. This is primarily due to timing of cash receipts on commercial contractual arrangements and the deferral of 2019/20 Broadcasting monies into the current quarter upon completion of all competitions.

Net capital expenditure on property, plant and equipment for the quarter was £1.8 million, a decrease of £1.3 million over the prior year quarter.

Net capital expenditure on intangible assets for the quarter was £51.6 million, a decrease of £106.6 million over the prior year quarter.

Net debt

Net Debt as of 30 September 2020 was £440.6 million, an increase of £56.1 million over the year, due to a decrease of £81.4 million in cash and cash equivalents, partially offset by favourable movements in the GBP:USD exchange rate. The decrease in cash and cash equivalents reflects the loss of 2020/21 season Matchday advance cash receipts with new seasonal facility sales currently on hold due to the uncertainties around fans returning to the stadium and the impact of deferred sponsorship payments. The gross USD debt principal remains unchanged.

Dividend

A semi-annual cash dividend of $0.09 per share will be paid on 7 January 2021, to shareholders of record on 30 November 2020. The stock will begin to trade ex-dividend on 25 November 2020.

About Manchester United

Manchester United is one of the most popular and successful sports teams in the world, playing one of the most popular spectator sports on Earth. Through our 142-year football heritage we have won 66 trophies, enabling us to develop what we believe is one of the world’s leading sports and entertainment brands with a global community of 1.1 billion fans and followers. Our large, passionate and highly engaged fan base provides Manchester United with a worldwide platform to generate significant revenue from multiple sources, including sponsorship, merchandising, product licensing, broadcasting and matchday initiatives which in turn, directly fund our ability to continuously reinvest in the club.

Cautionary Statements

This press release contains forward‑looking statements. You should not place undue reliance on such statements because they are subject to numerous risks and uncertainties relating to the Company’s operations and business environment, all of which are difficult to predict and many are beyond the Company’s control. Forward-looking statements include information concerning certain expectations and uncertainties related to the COVID-19 pandemic and the Company’s possible or assumed future results of operations, including descriptions of its business strategy. These statements often include words such as “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “seek,” “believe,” “estimate,” “predict,” “potential,” “continue,” “contemplate,” “possible” or similar expressions. The forward-looking statements contained in this press release are based on our current expectations and estimates of future events and trends, which affect or may affect our businesses and operations. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although the Company believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect its actual financial results or results of operations and could cause actual results to differ materially from those in these forward-looking statements. These factors are more fully discussed in the “Risk Factors” section and elsewhere in the Company’s Registration Statement on Form F-1, as amended (File No. 333-182535) and the Company’s Annual Report on Form 20-F (File No. 001-35627).

Non-IFRS Measures: Definitions and Use

  1. Adjusted EBITDA

Adjusted EBITDA is defined as loss/profit for the period before depreciation, amortization, loss/profit on disposal of intangible assets, exceptional items, net finance income/costs, and tax.

Adjusted EBITDA is useful as a measure of comparative operating performance from period to period and among companies as it is reflective of changes in pricing decisions, cost controls and other factors that affect operating performance, and it removes the effect of our asset base (primarily depreciation and amortization), material volatile items (primarily loss/profit on disposal of intangible assets and exceptional items), capital structure (primarily finance income/costs), and items outside the control of our management (primarily taxes). Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for an analysis of our results as reported under IFRS as issued by the IASB. A reconciliation of profit for the period to adjusted EBITDA is presented in supplemental note 2.

  1. Adjusted loss/profit for the period (i.e. adjusted net loss/income)

Adjusted loss/profit for the period is calculated, where appropriate, by adjusting for charges/credits related to exceptional items, foreign exchange gains/losses on unhedged US dollar denominated borrowings (including foreign exchange losses immediately reclassified from the hedging reserve following change in contract currency denomination of future revenues), and fair value movements on embedded foreign exchange derivatives, adding/subtracting the actual tax expense/credit for the period, and subtracting/adding the adjusted tax expense/credit for the period (based on an normalized tax rate of 21%; 2019: 21%). The normalized tax rate of 21% is the current US federal corporate income tax rate.

In assessing the comparative performance of the business, in order to get a clearer view of the underlying financial performance of the business, it is useful to strip out the distorting effects of the items referred to above and then to apply a ‘normalized’ tax rate (for both the current and prior periods) of the weighted average US federal corporate income tax rate of 21% (2019: 21%) applicable during the financial year. A reconciliation of loss/profit for the period to adjusted loss/profit for the period is presented in supplemental note 3.

3. Adjusted basic and diluted loss/earnings per share

Adjusted basic and diluted loss/earnings per share are calculated by dividing the adjusted loss/profit for the period by the weighted average number of ordinary shares in issue during the period. Adjusted diluted loss/earnings per share is calculated by adjusting the weighted average number of ordinary shares in issue during the period to assume conversion of all dilutive potential ordinary shares. There is one category of dilutive potential ordinary shares: share awards pursuant to the 2012 Equity Incentive Plan (the “Equity Plan”). Share awards pursuant to the Equity Plan are assumed to have been converted into ordinary shares at the beginning of the financial year. Adjusted basic and diluted loss/earnings per share are presented in supplemental note 3.

4. Net debt

Net debt is calculated as non-current and current borrowings minus cash and cash equivalents.

Key Performance Indicators

 

Three months ended

30 September

 

2020

2019

 

 

 

Revenue

 

 

Commercial % of total revenue

54.8%

59.4%

Broadcasting % of total revenue

43.7%

24.3%

Matchday % of total revenue

1.5%

16.3%

 

 

 

 

2020/21 Season

2019/20 Season

2019/20

Season

Home Matches Played

 

 

PL

1

3

4

UEFA competitions

1

1

Domestic Cups

1

Away Matches Played

 

 

PL

1

3

3

UEFA competitions

2

Domestic Cups

2

1

 

 

it

Other

 

 

Employees at period end

992

990

Employee benefit expenses % of revenue

66.0%

51.8%

CONSOLIDATED STATEMENT OF PROFIT OR LOSS

(unaudited; in £ thousands, except per share and shares outstanding data)

 

Three months ended

30 September

 

 

2020

2019

Revenue from contracts with customers

108,972

135,371

Operating expenses

(123,473)

(136,421)

(Loss)/profit on disposal of intangible assets

(12,595)

12,017

Operating (loss)/profit

(27,096)

10,967

Finance costs

(19,574)

(9,172)

Finance income

19,595

734

Net finance income/(costs)

21

(8,438)

(Loss)/profit before income tax

(27,075)

2,529

Income tax expense

(3,195)

(1,401)

(Loss)/profit for the period

(30,270)

1,128

 

 

 

Basic (loss)/earnings per share:

 

 

Basic (loss)/earnings per share (pence)

(18.58)

0.69

Weighted average number of ordinary shares used as the denominator in calculating basic (loss)/earnings per share (thousands)

162,939

164,573

Diluted (loss)/earnings per share:

 

 

Diluted (loss)/earnings per share (pence) (1)

(18.58)

0.68

Weighted average number of ordinary shares and potential ordinary shares used as the denominator in calculating diluted (loss)/earnings per share (thousands) (1)

162,939

164,735

(1) For the three months ended 30 September 2020, potential ordinary shares are anti-dilutive, as their inclusion in the diluted loss per share calculation would reduce the loss per share, and hence have been excluded.

CONSOLIDATED BALANCE SHEET

(unaudited; in £ thousands)

 

As of

 

30 September

2020

30 June

2020

30 September

2019

ASSETS

 

 

 

Non-current assets

 

 

 

Property, plant and equipment

253,026

254,439

251,112

Right-of-use assets

4,179

4,559

5,572

Investment properties

20,762

20,827

24,881

Intangible assets

780,646

775,170

785,653

Deferred tax asset

54,712

58,362

55,514

Trade receivables

25,078

43,694

41,905

Derivative financial instruments

693

1,609

44

 

1,139,096

1,158,660

1,164,681

Current assets

 

 

 

Inventories

3,542

2,186

2,664

Prepayments

19,930

6,503

15,382

Contract assets – accrued revenue

26,875

45,966

39,933

Trade receivables

69,742

115,985

36,060

Other receivables

438

239

15,269

Income tax receivable

1,223

1,214

643

Derivative financial instruments

1,764

1,174

297

Cash and cash equivalents

58,940

51,539

140,307

 

182,454

224,806

250,555

Total assets

1,321,550

1,383,466

1,415,236

CONSOLIDATED BALANCE SHEET (continued)

(unaudited; in £ thousands)

 

As of

 

30 September

2020

30 June

2020

30 September

2019

EQUITY AND LIABILITIES

 

 

 

Equity

 

 

 

Share capital

53

53

53

Share premium

68,822

68,822

68,822

Treasury shares

(21,305)

(21,305)

Merger reserve

249,030

249,030

249,030

Hedging reserve

(15,437)

(32,565)

(41,356)

Retained earnings

58,192

87,197

134,107

 

339,355

351,232

410,656

Non-current liabilities

 

 

 

Deferred tax liabilities

24,944

31,337

30,466

Contract liabilities – deferred revenue

26,970

18,759

26,988

Trade and other payables

56,645

51,322

32,046

Borrowings

497,292

520,010

522,437

Lease liabilities

3,223

3,326

3,992

Derivative financial instruments

8,219

9,136

3,760

 

617,293

633,890

619,689

Current liabilities

 

 

 

Contract liabilities – deferred revenue

165,483

171,574

206,643

Trade and other payables

188,806

216,093

171,441

Income tax liabilities

7,580

4,005

2,823

Borrowings

2,214

5,605

2,363

Lease liabilities

819

1,067

1,621

 

364,902

398,344

384,891

Total equity and liabilities

1,321,550

1,383,466

1,415,236

CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited; in £ thousands)

 

Three months ended

30 September

 

2020

2019

Cash flow from operating activities

 

 

Cash generated from/(used in) operations (see supplemental note 4)

72,410

(4,606)

Interest paid

(7,686)

(8,366)

Debt finance costs paid

(555)

Interest received

1

644

Tax paid

(2,415)

(1,489)

Net cash inflow/(outflow) from operating activities

62,310

(14,372)

Cash flow from investing activities

 

 

Payments for property, plant and equipment

(1,819)

(3,151)

Payments for intangible assets

(70,807)

(175,713)

Proceeds from sale of intangible assets

19,191

17,479

Net cash outflow from investing activities

(53,435)

(161,385)

Cash flow from financing activities

 

 

Principal elements of lease payments

(408)

(379)

Net cash outflow from financing activities

(408)

(379)

Net increase/(decrease) in cash and cash equivalents

8,467

(176,136)

Cash and cash equivalents at beginning of period

51,539

307,637

Effect of exchange rate changes on cash and cash equivalents

(1,066)

8,806

Cash and cash equivalents at end of period

58,940

140,307

SUPPLEMENTAL NOTES

1 General information

Manchester United plc (the “Company”) and its subsidiaries (together the “Group”) is a men’s and women’s professional football club together with related and ancillary activities. The Company incorporated under the Companies Law (as amended) of the Cayman Islands.

2 Reconciliation of (loss)/profit for the period to adjusted EBITDA

 

Three months ended

30 September

 

2020

£’000

2019

£’000

(Loss)/profit for the period

(30,270)

1,128

Adjustments:

 

 

Income tax expense

3,195

1,401

Net finance (income)/costs

(21)

8,438

Loss/(profit) on disposal of intangible assets

12,595

(12,017)

Amortization

31,543

32,187

Depreciation

3,786

3,642

Adjusted EBITDA

20,828

34,779

3 Reconciliation of (loss)/profit for the period to adjusted (loss)/profit for the period and adjusted basic and diluted (loss)/earnings per share

 

Three months ended

30 September

 

 

2020

£’000

2019

£’000

(Loss)/profit for the period

(30,270)

1,128

Foreign exchange (gains)/losses on unhedged US dollar denominated borrowings

(19,083)

2,448

Foreign exchange losses immediately reclassified from the hedging reserve following change in contract currency denomination of future revenues

14,837

Fair value movement on embedded foreign exchange derivatives

130

(79)

Income tax expense

3,195

1,401

Adjusted (loss)/profit before income tax

(31,191)

4,898

Adjusted income tax credit/(expense) (using a normalized tax rate of 21% (2019: 21%))

6,550

(1,029)

Adjusted (loss)/profit for the period (i.e. adjusted net (loss)/income)

(24,641)

3,869

 

 

 

Adjusted basic (loss)/earnings per share:

 

 

Adjusted basic (loss)/earnings per share (pence)

(15.12)

2.35

Weighted average number of ordinary shares used as the denominator in calculating basic (loss)/earnings per share (thousands)

162,939

164,573

Adjusted diluted (loss)/earnings per share:

 

 

Adjusted diluted (loss)/earnings per share (pence)

(15.12)

2.35

Weighted average number of ordinary shares and potential ordinary shares used as the denominator in calculating diluted (loss)/earnings per share (thousands)

162,939

164,735

4 Cash generated from/(used in) operations

 

Three months ended

30 September

 

2020

£’000

2019

£’000

(Loss)/profit for the period

(30,270)

1,128

Income tax expense

3,195

1,401

(Loss)/profit before income tax

(27,075)

2,529

Adjustments for:

 

 

Depreciation

3,786

3,642

Amortization

31,543

32,187

Loss/(profit) on disposal of intangible assets

12,595

(12,017)

Net finance (income)/costs

(21)

8,438

Non-cash employee benefit expense – equity-settled share-based payments

1,265

138

Foreign exchange losses/(gains) on operating activities

1,124

(373)

Reclassified from hedging reserve

(526)

2,854

Changes in working capital:

 

 

Inventories

(1,356)

(534)

Prepayments

(13,427)

(2,352)

Contract assets – accrued revenue

19,091

(401)

Trade receivables

53,306

2,344

Other receivables

(199)

(14,081)

Contract liabilities – deferred revenue

2,120

10,131

Trade and other payables

(9,816)

(37,111)

Cash generated from/(used in) operations

72,410

(4,606)

 

Investor Relations:

Corinna Freedman

Head of Investor Relations

+44 161 868 8431

[email protected]

Media Relations:

Charlie Brooks

Director of Communications

+44 161 868 8148

[email protected]

KEYWORDS: United Kingdom Europe

INDUSTRY KEYWORDS: Soccer Professional Services Sports Finance

MEDIA:

Logo
Logo

Hanes Is Happy to Be the ‘Official Smile’ of the 94th Annual Macy’s Thanksgiving Day Parade®

Hanes Is Happy to Be the ‘Official Smile’ of the 94th Annual Macy’s Thanksgiving Day Parade®

America’s No. 1 basic apparel brand continues its #MaskAround campaign by partnering with the iconic Parade to provide face masks, most featuring a bold smile screen print, to help protect staff, volunteers and participants

WINSTON-SALEM, N.C.–(BUSINESS WIRE)–Hanes, America’s No. 1 basic apparel brand, is helping millions smile for the holidays as it partners with the team behind the world-renowned Macy’s Thanksgiving Day Parade®.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201112005578/en/

As the “Official Smile” of the 94th Annual Macy’s Thanksgiving Day Parade, Hanes is providing thousands of face masks to Parade staff, volunteers and participants. Vibrant colors, including red, blue, green, orange, pink and yellow, highlight a bold screen printed smile across the front of the Hanes and Macy’s Parade co-branded masks for Parade support teams and performers. (Photo: Business Wire)

As the “Official Smile” of the 94th Annual Macy’s Thanksgiving Day Parade, Hanes is providing thousands of face masks to Parade staff, volunteers and participants. Vibrant colors, including red, blue, green, orange, pink and yellow, highlight a bold screen printed smile across the front of the Hanes and Macy’s Parade co-branded masks for Parade support teams and performers. (Photo: Business Wire)

As the “Official Smile” of the 94th Annual Macy’s Thanksgiving Day Parade, Hanes is providing thousands of face masks to Parade staff, volunteers and participants. Vibrant colors, including red, blue, green, orange, pink and yellow, highlight a bold screen printed smile across the front of the Hanes and Macy’s Parade co-branded masks for Parade support teams and performers.

“HanesBrands has taken a leadership role in encouraging people to wear masks during the pandemic, and this collaboration between Hanes and the Macy’s Thanksgiving Day Parade is a natural extension of that effort,” said Ann Fritchman, chief customer officer for HanesBrands. “We are thrilled Hanes is the ‘Official Smile’ of the Parade and are excited to help all participants remain safe while smiling through this iconic event.”

Jordan Dabby, producer of the Macy’s Thanksgiving Day Parade, said: “As we safely reimagined this year’s Macy’s Parade we knew immediately that at the top of our health and wellness plan would be face masks to help protect the incredible volunteers and participants who are coming together to give the nation this cherished holiday gift. Thanks to Hanes our smiles will shine through as we kick-off the holiday season live from 34th Street this Thanksgiving.”

In response to the global pandemic, HanesBrands leveraged its design and manufacturing expertise to quickly pivot operations to the production of all-cotton cloth face coverings and medical gowns beginning in March. Hanes introduced its #MaskAround campaign in July to underscore the importance of wearing a face mask in public to help slow the spread of COVID-19. As part of the campaign and to ensure those in need have access to face coverings, Hanes has also donated 1 million face masks to those experiencing homelessness across the country.

In addition to providing face masks, Hanes is helping generate excitement ahead of the Parade. The brand is launching an Instagram-based giveaway on Nov. 17 at www.Instagram.com/Hanes. Three winners chosen at random will each receive a gift basket filled with the limited-edition, official Hanes x Macy’s Thanksgiving Day Parade smile masks, exclusive Parade gear and a $100 Macy’s gift card. To enter, participants simply need to like Hanes on Instagram, like the promotional post and tag two friends who make them smile.

For more information on the Hanes #MaskAround campaign and the brand’s donation of 1 million face masks to those experiencing homelessness, visit www.HanesforGood.com.

For more information about the Macy’s Thanksgiving Day Parade, visit www.Macys.com/Parade.

Hanes

Hanes, America’s No. 1 apparel brand, is a leading brand of intimate apparel, underwear, sleepwear, socks and casual apparel. Hanes products can be found at leading retailers nationwide and online direct to consumers at www.Hanes.com.

Macy’s Thanksgiving Day Parade

For more than 90 years, the Macy’s Thanksgiving Day Parade has marked the official start of the holiday season. With more than 50 million viewers nationwide, the Macy’s Thanksgiving Day Parade is a national icon that has grown into a world-famous holiday event. Featuring Macy’s signature giant character balloons, fantasy floats, marching bands, clowns, celebrity and large group performances, and the one-and-only Santa Claus, the annual spectacle continues to bring families together to create cherished holiday memories. For more information on the Macy’s Parade please visit macys.com/parade.

HanesBrands

HanesBrands (NYSE: HBI) is a socially responsible leading marketer of everyday basic innerwear and activewear apparel in the Americas, Europe, Australia and Asia-Pacific. The company markets T-shirts, bras, panties, shapewear, underwear, socks, hosiery, and activewear under some of the world’s strongest apparel brands, including Hanes, Champion, Bonds, Maidenform, DIM,Bali, Playtex, Bras NThings, Nur Die/Nur Der, Alternative, L’eggs, JMS/Just My Size, Lovable, Wonderbra, Berlei, and Gear for Sports. More information about the company and its award-winning corporate social responsibility initiatives may be found at www.Hanes.com/corporate. Visit our newsroom at https://newsroom.hanesbrands.com/. Connect with the company via social media: Twitter (@hanesbrands), Facebook (www.facebook.com/hanesbrandsinc), Instagram (@hanesbrands), and LinkedIn (@Hanesbrandsinc).

Carole Crosslin, HanesBrands

336-671-3704 (mobile)

[email protected]

Orlando Veras, Macy’s

646-206-3073

[email protected]

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Retail Textiles Manufacturing Fashion

MEDIA:

Photo
Photo
As the “Official Smile” of the 94th Annual Macy’s Thanksgiving Day Parade, Hanes is providing thousands of face masks to Parade staff, volunteers and participants. Vibrant colors, including red, blue, green, orange, pink and yellow, highlight a bold screen printed smile across the front of the Hanes and Macy’s Parade co-branded masks for Parade support teams and performers. (Photo: Business Wire)

ATTO Technology Announces Support for Apple’s Next Generation Operating System macOS® 11 Big Sur

Complete hardware and software portfolio supports latest macOS release

AMHERST, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) — ATTO Technology, Inc., a global leader of network, storage connectivity and infrastructure solutions for data-intensive computing environments for over 30 years, today reaffirmed its commitment to Apple® technology innovations by announcing support for macOS® 11 Big Sur.

macOS 11 Big Sur is the most significant operating system upgrade from Apple since the introduction of Mac® OS X in 2001. It features a major redesign of the user interface as well as support for Apple’s ARM64-based processors.

“We’ve supported the Apple community with connectivity innovations for the last 30 years and continue to do so with Big Sur,” said Timothy J. Klein, president and CEO, ATTO Technology. “Content creators love macOS and we’re happy to provide the high-performance connectivity they need.”

ATTO Technology is a network and storage connectivity manufacturer whose products power high-performance, demanding workflows for media and entertainment, government, education, and scientific users. From Thunderbolt™ to Ethernet, Fibre Channel to SAS/SATA, ATTO products are the highest performing, most reliable and easiest to use connectivity solutions available for Mac environments.

Apple is the platform of choice for creative professionals who work with demanding design and digital production workflows where team collaboration is often essential. Digital assets continue to evolve in complexity and number which naturally leads to more and more data moving through networks. ATTO Technology supplies the connectivity purpose made to address these challenges.

Data density and complexity typify most workflows today, like in science and education where Apple computers are popular and widely used. The same technology from ATTO that Hollywood studios rely upon is equally effective across all industries.

Apple platform developers and OEMs look to ATTO for stable and reliable testbed connectivity to storage and networks. Software and application developers can take advantage of support VMware Vsphere environments with Thunderbolt connectivity using ATTO ThunderLink® Thunderbolt adapters.

Products in the ATTO portfolio supporting macOS Big Sur include:

For a complete list of supported products and to browse the entire ATTO Technology family of connectivity solutions, visit: www.atto.com.

P
urchase ATTO products through leading
Value Added
Resellers, System Integrators and the ATTO Web Store. Learn more:
www.atto.com/howtobuy/

Follow ATTO on

Twitter

,

LinkedIn

,

Instagram

and

Facebook

(
@
ATTOTechnology
).

ABOUT ATTO

For over 30 years ATTO Technology, Inc. has been a global leader across the IT and media & entertainment markets, specializing in network and storage connectivity and infrastructure solutions for the most data-intensive computing environments. ATTO works with customers and partners to deliver end-to-end solutions to better store, manage and deliver data, often as an extension of their design teams. ATTO manufactures host adapters, smart NICs, storage appliances and controllers, intelligent bridges, Thunderbolt™ adapters, and software. ATTO solutions provide a high level of connectivity to all storage interfaces, including Fibre Channel, SAS, SATA, iSCSI, Ethernet, NVMe and Thunderbolt. ATTO is the Power Behind the Storage.

All trademarks, trade names, service marks and logos referenced herein belong to their respective companies.

Contact: Richard Root

ATTO Technology, Inc.
[email protected]
Phone: +1 (716) 691-1999 x285
Fax: +1 (716) 691-9353